UK markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
479.57+3.22 (+0.68%)
At close: 04:00PM EDT
479.57 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 39.56B
Enterprise value 40.18B
Trailing P/E 47.35
Forward P/E 43.67
PEG ratio (5-yr expected) 4.55
Price/sales (ttm)10.93
Price/book (mrq)26.65
Enterprise value/revenue 10.97
Enterprise value/EBITDA 33.00

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 3-5.41%
S&P500 52-week change 320.07%
52-week high 3583.39
52-week low 3372.50
50-day moving average 3539.03
200-day moving average 3504.57

Share statistics

Avg vol (3-month) 3411.81k
Avg vol (10-day) 3468.86k
Shares outstanding 583.05M
Implied shares outstanding 683.35M
Float 882.19M
% held by insiders 10.93%
% held by institutions 192.24%
Shares short (28 Mar 2024) 41.76M
Short ratio (28 Mar 2024) 44.54
Short % of float (28 Mar 2024) 42.71%
Short % of shares outstanding (28 Mar 2024) 42.11%
Shares short (prior month 29 Feb 2024) 41.69M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 316 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 23.08%
Operating margin (ttm)27.21%

Management effectiveness

Return on assets (ttm)22.83%
Return on equity (ttm)80.74%

Income statement

Revenue (ttm)3.66B
Revenue per share (ttm)44.07
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)N/A
Net income avi to common (ttm)845.04M
Diluted EPS (ttm)10.05
Quarterly earnings growth (yoy)13.00%

Balance sheet

Total cash (mrq)453.93M
Total cash per share (mrq)5.46
Total debt (mrq)1.07B
Total debt/equity (mrq)71.90%
Current ratio (mrq)1.57
Book value per share (mrq)17.88

Cash flow statement

Operating cash flow (ttm)906.51M
Levered free cash flow (ttm)693.69M